New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient ...Middle East

PR Newswire - Economy
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications SALT LAKE CITY, Sept. 1, 2022 /PRNewswire/ -- Fluidx Medical announces completion of trial enrollment for its novel embolic device, GPX. In this multi-center trial, GPX was used to treat a variety...

Hence then, the article about new liquid embolic multi center trial successfully enrolls final patient was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient )

Apple Storegoogle play

Last updated :

Also on site :